Nanoparticles targeting the infarcted heart

181Citations
Citations of this article
233Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We report a nanoparticulate system capable of targeting the heart after myocardial infarction (MI). Targeting is based on overexpression of angiotensin II type 1 (AT1) receptor in the infarcted heart. Liposomes 142 nm in diameter were conjugated with a ligand specific to AT1. The nanoparticles were able to specifically target cardiac cells in vitro, and in the infarcted heart after intravenous injection in vivo. This system may be useful for delivering therapeutic agents specifically to the infarcted heart. © 2011 American Chemical Society.

Cite

CITATION STYLE

APA

Dvir, T., Bauer, M., Schroeder, A., Tsui, J. H., Anderson, D. G., Langer, R., … Kohane, D. S. (2011). Nanoparticles targeting the infarcted heart. Nano Letters, 11(10), 4411–4414. https://doi.org/10.1021/nl2025882

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free